Status
N/A
not available
Share
Funding data
Details
Country
Finland
Type
Equity
Sector
HealthcareBiotechnology
Description
“Askel offers a unique way to rebuild joint surfaces for pain-free movement. COPLA® is a medical device already on the 250M€ market for animal health with excellent clinical results. The next step is to enter into the 2.2B$ human market.”